Nasdaq Stockholm

Swedish Orphan Biovitrum AB (publ)

ISIN SE0000872095Filings at the FI

At a glance

Most recent filing on July 31, 2026 — a sale by Guido Oelkers on Jul 29, 2026.

We hold 257 visible filings, going back to November 16, 2016.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 257 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 257. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Guido Oelkers Chief executive officer
37,022,611 SEKOpen-market sale
TradedJul 29, 2026FiledJul 31, 2026
Duane Barnes Other senior executive
46,247,074 SEKOpen-market sale
TradedJul 28, 2026FiledJul 30, 2026
Guido Oelkers Chief executive officer
46,400,000 SEKOpen-market sale
TradedJul 28, 2026FiledJul 30, 2026
Guido Oelkers Chief executive officer
45,740,000 SEKOpen-market sale
TradedJul 27, 2026FiledJul 30, 2026
Christin Wesström Other senior executive
17,055,123 SEKOpen-market sale
TradedJul 28, 2026FiledJul 30, 2026